Loading...
Header Logo
Keywords
Last Name
Institution

Marc Fisher

Concepts (171)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
36
2017
472
8.890
Why?
Brain Ischemia
28
2017
169
7.300
Why?
Neuroprotective Agents
9
2011
39
2.480
Why?
Cerebrovascular Circulation
12
2012
97
2.180
Why?
Infarction, Middle Cerebral Artery
7
2009
37
2.140
Why?
Clinical Trials as Topic
14
2015
298
2.080
Why?
Tissue Plasminogen Activator
6
2010
83
1.670
Why?
Diffusion Magnetic Resonance Imaging
10
2009
64
1.500
Why?
Periodicals as Topic
3
2017
96
1.330
Why?
Disease Models, Animal
14
2013
1154
1.320
Why?
Editorial Policies
2
2017
23
1.310
Why?
Thrombolytic Therapy
6
2013
122
1.290
Why?
Platelet Aggregation Inhibitors
4
2009
177
1.150
Why?
Fibrinolytic Agents
4
2010
130
1.100
Why?
Magnetic Resonance Imaging
7
2009
1005
1.030
Why?
Thrombectomy
2
2015
30
0.980
Why?
Ischemic Attack, Transient
3
2008
48
0.970
Why?
Rats
17
2013
1675
0.930
Why?
Reperfusion
5
2010
16
0.840
Why?
Drug Design
3
2010
93
0.820
Why?
Animals
30
2014
14096
0.800
Why?
Humans
35
2017
34003
0.680
Why?
Treatment Outcome
9
2013
2617
0.680
Why?
Magnetic Resonance Angiography
3
2006
92
0.660
Why?
Time Factors
13
2015
2555
0.650
Why?
Health Planning Guidelines
2
2007
26
0.620
Why?
Rats, Sprague-Dawley
11
2008
454
0.610
Why?
Brain
6
2007
850
0.590
Why?
Ticlopidine
2
2006
58
0.580
Why?
Anticoagulants
2
2009
211
0.570
Why?
Granulocyte Colony-Stimulating Factor
2
2013
29
0.550
Why?
Reperfusion Injury
3
2010
34
0.520
Why?
Acute Disease
8
2010
526
0.510
Why?
Freezing
1
2011
12
0.480
Why?
Embolism
2
2008
20
0.470
Why?
Brain Injuries
2
2013
82
0.460
Why?
Thrombophilia
1
2010
13
0.450
Why?
Aspirin
2
2009
138
0.440
Why?
Intracellular Signaling Peptides and Proteins
1
2011
209
0.420
Why?
Male
19
2013
17187
0.420
Why?
Intracranial Embolism
1
2009
13
0.410
Why?
Research
2
2009
138
0.410
Why?
Cerebral Infarction
2
2007
42
0.410
Why?
Behavior, Animal
2
2007
140
0.410
Why?
Gadolinium
1
2009
53
0.410
Why?
Laser-Doppler Flowmetry
1
2008
3
0.400
Why?
Brain Infarction
1
2008
11
0.400
Why?
Hyperoxia
1
2008
10
0.390
Why?
Warfarin
1
2009
79
0.380
Why?
Telemedicine
2
2009
85
0.380
Why?
Contrast Media
1
2009
232
0.370
Why?
Cerebral Arteries
1
2007
11
0.350
Why?
Biomedical Technology
1
2007
4
0.350
Why?
Rats, Wistar
4
2013
148
0.340
Why?
Membrane Proteins
1
2011
631
0.340
Why?
Middle Cerebral Artery
1
2006
28
0.320
Why?
Dimethyl Sulfoxide
1
2005
12
0.320
Why?
Drug Evaluation, Preclinical
1
2005
60
0.310
Why?
Device Approval
1
2005
4
0.310
Why?
Recovery of Function
3
2013
144
0.290
Why?
Research Design
2
2005
382
0.290
Why?
Cerebral Cortex
1
2005
173
0.290
Why?
Diffusion
5
2008
68
0.280
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2005
144
0.280
Why?
Stem Cell Transplantation
1
2003
35
0.270
Why?
Neurons
2
2011
604
0.260
Why?
Heparin, Low-Molecular-Weight
1
2002
23
0.250
Why?
Disease Management
1
2003
118
0.250
Why?
Blood Pressure
3
2010
366
0.250
Why?
Heparin
1
2002
96
0.240
Why?
Astrocytes
1
2002
65
0.240
Why?
Drug Therapy, Combination
3
2009
313
0.230
Why?
Tomography, X-Ray Computed
1
2006
841
0.230
Why?
Regional Blood Flow
2
2008
77
0.180
Why?
Health Services Needs and Demand
1
2017
160
0.160
Why?
Randomized Controlled Trials as Topic
2
2009
348
0.160
Why?
Health Services Accessibility
1
2017
301
0.150
Why?
Diagnostic Imaging
2
2008
163
0.140
Why?
Injections, Intravenous
2
2005
135
0.140
Why?
Language
1
2014
59
0.140
Why?
Cerebral Hemorrhage
2
2005
41
0.140
Why?
Patient Selection
2
2006
286
0.130
Why?
Secondary Prevention
2
2003
92
0.130
Why?
Recombinant Proteins
2
2006
597
0.130
Why?
Cognition Disorders
1
2013
171
0.120
Why?
Vascular Surgical Procedures
1
2013
131
0.120
Why?
Tetrazolium Salts
2
2008
14
0.120
Why?
Factor V Deficiency
1
2010
1
0.110
Why?
Antithrombin III Deficiency
1
2010
2
0.110
Why?
Protein S Deficiency
1
2010
2
0.110
Why?
Protein C Deficiency
1
2010
3
0.110
Why?
Foramen Ovale, Patent
1
2010
9
0.110
Why?
Cell Death
1
2011
202
0.110
Why?
Middle Aged
3
2009
9901
0.110
Why?
Cost-Benefit Analysis
1
2010
171
0.110
Why?
Risk Factors
2
2008
3059
0.110
Why?
Image Processing, Computer-Assisted
3
2007
434
0.110
Why?
Cortical Spreading Depression
1
2009
3
0.100
Why?
Hospital Units
1
2009
8
0.100
Why?
Health Care Sector
1
2009
18
0.100
Why?
Magnetic Field Therapy
1
2008
2
0.100
Why?
Infusions, Intra-Arterial
1
2008
7
0.100
Why?
Case-Control Studies
1
2010
660
0.100
Why?
Peptides
1
2011
414
0.100
Why?
Species Specificity
1
2009
282
0.100
Why?
Functional Laterality
2
2006
116
0.100
Why?
Blood Glucose
1
2010
367
0.100
Why?
Guidelines as Topic
1
2009
117
0.100
Why?
Infusions, Intravenous
1
2008
136
0.090
Why?
Drug Administration Schedule
1
2008
217
0.090
Why?
Radiography
2
2006
282
0.090
Why?
Hemorrhage
1
2009
153
0.090
Why?
Electrocardiography
1
2009
297
0.090
Why?
Equipment Design
1
2008
222
0.090
Why?
Practice Guidelines as Topic
1
2010
437
0.090
Why?
Injury Severity Score
1
2007
49
0.090
Why?
United States
2
2008
4055
0.090
Why?
Cells, Cultured
1
2011
1706
0.090
Why?
Virginia
1
2007
11
0.090
Why?
Benzenesulfonates
1
2006
14
0.080
Why?
Brain Mapping
1
2007
155
0.080
Why?
Rats, Inbred WKY
1
2005
9
0.080
Why?
Body Temperature
1
2005
45
0.080
Why?
Drug Industry
1
2005
30
0.080
Why?
Adult
2
2009
9828
0.080
Why?
Legislation, Drug
1
2005
9
0.080
Why?
Equipment Safety
1
2005
14
0.080
Why?
Product Surveillance, Postmarketing
1
2005
14
0.080
Why?
Cerebrovascular Disorders
1
2005
42
0.080
Why?
Carbon Dioxide
1
2005
53
0.080
Why?
Drug Approval
1
2005
13
0.080
Why?
Software
1
2007
249
0.080
Why?
Quality of Health Care
1
2008
357
0.080
Why?
United States Food and Drug Administration
1
2005
41
0.080
Why?
Models, Animal
1
2005
167
0.080
Why?
Aged
2
2008
7693
0.070
Why?
Thrombosis
1
2006
122
0.070
Why?
Risk Assessment
1
2009
1081
0.070
Why?
Heart Rate
1
2005
216
0.070
Why?
Risk
1
2005
346
0.070
Why?
Pharmaceutical Preparations
1
2005
73
0.070
Why?
Regression Analysis
1
2005
435
0.070
Why?
Recurrence
1
2005
406
0.070
Why?
Hydrogen-Ion Concentration
1
2005
327
0.070
Why?
Oxygen
1
2005
205
0.070
Why?
Dipyridamole
1
2003
45
0.070
Why?
Drug Combinations
1
2003
99
0.070
Why?
Disease Progression
1
2005
468
0.070
Why?
Odds Ratio
1
2005
636
0.070
Why?
Multivariate Analysis
1
2005
721
0.070
Why?
Drug Synergism
1
2003
100
0.070
Why?
Decision Making
1
2004
209
0.060
Why?
Treatment Failure
1
2003
120
0.060
Why?
Combined Modality Therapy
1
2003
254
0.060
Why?
Prospective Studies
1
2007
1667
0.060
Why?
Severity of Illness Index
1
2005
864
0.060
Why?
Microscopy, Electron
1
2002
233
0.060
Why?
Aged, 80 and over
1
2008
2922
0.060
Why?
Follow-Up Studies
1
2005
1528
0.060
Why?
Water
1
2002
178
0.060
Why?
Mice
1
2011
7043
0.060
Why?
Algorithms
1
2004
653
0.050
Why?
Female
2
2008
19057
0.050
Why?
Urbanization
1
2017
2
0.050
Why?
Nursing Staff, Hospital
1
2017
52
0.040
Why?
Area Under Curve
1
2013
74
0.030
Why?
Neuropsychological Tests
1
2013
229
0.030
Why?
Silicon
1
2006
15
0.020
Why?
Sutures
1
2006
20
0.020
Why?
Perfusion
1
2006
73
0.020
Why?
Surface Properties
1
2006
206
0.020
Why?
Fisher's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_